Mark Hallett MDDistinguished NIH Investigator Emeritus, National Institute of Neurological Disorders and Stroke, National Institutes of Health; Past-President, Functional Neurological Disorder Society, Bethesda, Maryland
Dr. Hallett recently retired from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH), but he remains connected there as Distinguished NIH Investigator Emeritus. He is also the current Past-President of the Functional Neurological Disorder Society. His research work mainly deals with principles of motor control and the pathophysiology of movement disorders.
Dr. Hallett is a Past President of the International Federation of Clinical Neurophysiology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the International Parkinson and Movement Disorder Society, and a past Vice-President of the American Academy of Neurology. He is a past Editor-in-Chief of Clinical Neurophysiology and a past Associate Editor of Brain. He has served, and is now serving, on many editorial boards. He is the recipient of many honors and has delivered many named lectures worldwide.
Dr. Hallett obtained his medical degree from Harvard Medical School, interned at the Peter Bent Brigham Hospital, and trained in neurology at Massachusetts General Hospital. He completed fellowship training in neurophysiology at the National Institutes of Health and at the Institute of Psychiatry in London. From 1976 to 1984, Dr. Hallett was the Chief of the Clinical Neurophysiology Laboratory at the Brigham and Women's Hospital. Before he left Boston, he was Associate Professor of Neurology at Harvard Medical School. From 1984 to 2022, he was Chief of the Human Motor Control Section at NINDS, NIH. He also served as Clinical Director, NINDS, from 1984 to 2000.
Past-President, Functional Neurological Disorder Society
Distinguished NIH Investigator Emeritus, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland
MD: Harvard Medical School, Boston, Massachusetts
D.M.(hon): University of Hamburg, Hamburg, Germany
Fellowship (neurophysiology): National Institutes of Health, Bethesda, Maryland
Fellowship (neurophysiology): Institute of Psychiatry, London, UK
Principles of motor control; pathophysiology of movement disorders
Mark Hallett, MD, serves on the Advisory Boards of Brainsway, VoxNeuro, and QuantalX and has consulted for Janssen.
Recent Contributions to PracticeUpdate:
- Brain Network Function and Clinical Neurologic Disorders
- New Data on Calcium Channel Modulator for Essential Tremor
- Istradefylline as an Adjunct to Levodopa in Parkinson’s Disease
- Determination of Brain Death/Death by Neurologic Criteria
- SNAREopathies: Diversity in Mechanisms and Symptoms
- 2019 Top Stories in Neurology: Functional Neurological Disorders Can Be Treated
- AAN 2019: Recommendations From Dr. Mark Hallett
- High Prevalence of Neutralizing Antibodies After Long-Term Botulinum Neurotoxin Therapy
- 2018 Top Stories in Neurology: Gene Therapy
- Zonisamide as an Adjunct to Levodopa for DLB Parkinsonism